NCT06319248: MID-STEP (MIDodrine for Sepsis Treatment and Early vasoPressor Weaning) Trial
- State
- Under way
- Phase
- Phase 2
- People
- 308 planned
- Started
- 14 May 2024
- Primary completion
- 30 May 2029
- Arms
- Standard of Care with Midodrine Group
- Results
- None posted
- 20 Mar 2024: Trial registered
- 14 May 2024: Trial started